Evaluation of the JUICE HA® as an Anti-sarcopenia
China Medical University Hospital
60 participants
Jun 23, 2025
INTERVENTIONAL
Conditions
Summary
This study plans to recruit 60 participants aged 65 years and older who have been diagnosed with sarcopenia by a physician. Participants will be randomly assigned into JUICE HA® supplement and placebo group. All of the participants will be asked to take 15 mL/day of JUICE HA® supplement or placebo group for 12 weeks. The aim of this trial is to evaluate the potential of JUICE HA® to enhance physiological status (muscle mass and functional fitness) and to improve the quality of life in patients with sarcopenia.
Eligibility
Inclusion Criteria1
- Participants that have been diagnosed with sarcopenia by a physician and meet the AWGS 2019 criteria for sarcopenia.
Exclusion Criteria1
- Participants with a history of severe lower extremity musculoskeletal injuries within the past six months or those who have a fear of blood sampling will be excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bottle of 15 mL liquid (non-effective product) will be taken once a day for 12 weeks.
Bottle of 15 mL JUICE HA® supplement will be taken once a day for 12 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06950125